News and updates — Page 3 of 24 — German Market Access

G-BA decisions from 1 Aug 2024

Here are the latest G-BA decisions from the G-BA meeting held on 1 Aug 2024 on the early benefit assessments of Rezzayo,

Here are the latest G-BA decisions from the G-BA meeting held on 4 July 2024, which covered only procedural decisions. A complete

Here are the G-BA decisions from the G-BA meeting held on 4 July 2024 on the early benefit assessments of Agamree, Loargys,

In April 2024, I wrote a guest post for Market Access Today. Introduction Entering the dynamic realm of pharmaceutical pricing in Germany,

Are confidential drug prices coming to Germany? Until now, the reimbursed prices of drugs are in the public domain (Lauer Taxe), but